A Comparative Analysis of Intertransverse Nerve Block and Paravertebral Nerve Block in Endoscopic Hepatectomy

Status

Active, not recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06553495

Enrollment

Registered

2024-08-14

Start date

2024-08-01

Completion date

2026-12-31

Last updated

2024-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

This study aims to compare the analgesic effect of intertransverse nerve block and paravertebral nerve block after endoscopic hepatectomy, evaluate its effectiveness and safety, and provide new ideas and clinical basis for postoperative pain management of liver surgery.

Detailed description

This study was a prospective, double-blind, randomized controlled trial. Patients who were eligible for laparoscopic partial liver resection in our center were included, with intertransverse nerve block as the experimental group and paravertebral nerve block as the control group. Through the analysis of postoperative pain score 30min to 24h, the number of effective analgesic pump compressions within 24h, the amount of analgesic drugs used, complications and other data, To evaluate the efficacy and safety of intertransverse nerve block in patients undergoing laparoscopic partial liver resection.

Interventions

OTHERNerve block

Analgesic effect of different nerve blocks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

1: 1.18-80 years old adult, BMI\<27.9kg/m2 2: 2. American Society of Anesthesiologists ASA Grade I-III 3: 3. Patients with laparoscopic partial liver resection such as liver tumors 4: 4. Willing to participate in this study and sign the informed consent form \-

Exclusion criteria

1. 1\. The patient or family member refuses to sign the informed consent form 2. 2\. Blood coagulation dysfunction, local infection 3. 3\. Those who have communication, communication disorders or mental abnormalities 4. 4\. Patients with severe heart, pulmonary and renal insufficiency or patients with central system diseases 5. 5\. For any reason, it cannot be matched with the study or the researcher believes that it is not appropriate to be included in this experiment. \-

Design outcomes

Primary

Measure	Time frame
The number of effective compressions of the analgesic pump within 24 hours after surgery	Within 24 hours after the operation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026